Premium
Neuphoria Therapeutics Inc (NEUP)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Armistice Capital LLC | Institution | 1 033 796 | 19,13% | US$ 4,83M | 2024-12-31 |
| Armistice Capital Master Fund Ltd. | Institution | 1 033 796 | 19,13% | US$ 4,83M | 2024-12-31 |
| Lynx1 Capital Management LP | Institution | 875 328 | 16,20% | US$ 4,09M | 2026-03-31 |
| Lynx1 Master Fund LP | Institution | 875 328 | 16,20% | US$ 4,09M | 2025-12-26 |
| AdvisorShares Investments, LLC | Institution | 155 367 | 2,87% | US$ 725,56k | 2026-03-31 |
| Shay Capital LLC | Institution | 151 010 | 2,79% | US$ 705,22k | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 142 183 | 2,63% | US$ 663,99k | 2026-03-31 |
| Coastlands Capital LP | Institution | 120 000 | 2,22% | US$ 560,40k | 2025-11-05 |
| Coastlands Capital Partners LP | Institution | 120 000 | 2,22% | US$ 560,40k | 2025-11-05 |
| Vanguard Capital Management, LLC | Institution | 98 516 | 1,82% | US$ 460,07k | 2026-03-31 |
| Dr. Robert Corringham | Initiés | 86 862 | 1,61% | US$ 405,65k | 2025-09-29 |
| Eleanor Lipyanek | Initiés | 86 861 | 1,61% | US$ 405,64k | 2025-09-29 |
| Squadron Capital Management Llc | Institution | 76 728 | 1,42% | US$ 358,32k | 2026-03-31 |
| Apeiron Investment Group Limited | Institution | 72 618 | 1,34% | US$ 339,13k | 2025-01-24 |
| Geode Capital Management, LLC | Institution | 52 007 | 0,96% | US$ 242,87k | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 47 443 | 0,88% | US$ 221,56k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 33 589 | 0,62% | US$ 156,86k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 30 000 | 0,56% | US$ 140,10k | 2026-03-31 |
| FNY Investment Advisers, LLC | Institution | 26 500 | 0,49% | US$ 123,76k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 19 331 | 0,36% | US$ 90,28k | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 14 000 | 0,26% | US$ 65,38k | 2026-03-31 |
| Virtu Financial, Inc. | Institution | 12 033 | 0,22% | US$ 56,19k | 2026-03-31 |
| Commonwealth Equity Services, LLC | Institution | 11 222 | 0,21% | US$ 52,41k | 2026-03-31 |
| MRL Ventures Fund LLC | Institution | 10 027 | 0,19% | US$ 46,83k | 2026-03-31 |
| Dr. Spyridon Papapetropoulos | Initiés | 9 888 | 0,18% | US$ 46,18k | 2025-09-29 |
| UBS Asset Management AG | Institution | 2 316 | 0,04% | US$ 10,82k | 2026-03-31 |
| Dr. Jane Ryan | Initiés | 230 | 0,00% | US$ 1,07k | 2025-09-29 |
| Rhumbline Advisers Ltd Partnership | Institution | 202 | 0,00% | US$ 943,34 | 2026-03-31 |
| Mr. Peter Miles Davies | Initiés | 126 | 0,00% | US$ 588,42 | 2025-09-26 |
| Mr. David Wilson | Initiés | 117 | 0,00% | US$ 546,39 | 2025-09-29 |
| Morgan Stanley | Institution | 58 | 0,00% | US$ 270,86 | 2026-03-31 |
| Mr. Alan Fisher | Initiés | 0 | 0,00% | - | 2025-09-29 |
| Diadema Partners LP | Institution | 0 | 0,00% | - | 2026-03-31 |
| The Vanguard Group, Inc. | Institution | 0 | 0,00% | - | 2026-01-01 |
| Jane Street Group, LLC | Institution | 0 | 0,00% | - | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 0 | 0,00% | - | 2026-03-31 |
| Tower Research Capital Europe Limited | Institution | 0 | 0,00% | - | 2026-03-31 |
| XTX Markets Limited | Institution | 0 | 0,00% | - | 2026-03-31 |
| Persistent Asset Partners Limited | Institution | 0 | 0,00% | - | 2026-03-31 |
| Bank of America Corporation | Institution | 0 | 0,00% | - | 2026-03-31 |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Institution | 0 | 0,00% | - | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
